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Abstract. The current study presents a rare case of small 
cell lung cancer (SCLC) with endobronchial growth in a 
68‑year‑old male. Chest CT scans revealed an ill‑defined mass 
in the upper lobe of the right lung, with ipsilateral mediastinial 
lymph node swelling. An endobronchial polypoid tumor in the 
right B3 bronchus was located by bronchoscopic examination. 
The analysis of a biopsy specimen obtained from the tumor 
resulted in a diagnosis of SCLC. Although extremely rare, this 
case highlights the importance of considering a diagnosis of 
SCLC in patients presenting with a pulmonary tumor adjacent 
to the bronchus, with an endobronchial polypoid lesion.
Introduction
Although small cell lung cancer (SCLC) is one of the most 
common histological types of primary lung cancer, endobron-
chial extension is extremely rare (1,2). A clinical differential 
diagnosis of endobronchial lesions may include a variety of 
conditions, such as non-malignant tumors, primary lung 
carcinoma other than adenocarcinoma and endobronchial 
metastasis of carcinoma from extrapulmonary organs (3-8). 
The current study presents the case of a patient with SCLC 
and endobronchial growth. Written informed consent was 
obtained from the patient.
Case report
Patient presentation. A 68-year-old male was referred to 
the Mito Medical Center (University of Tsukuba, Mito, 
Japan) following a three-month history of hoarseness. Upon 
admission, laboratory tests revealed that the patient had 
hemoglobin levels of 12.5 g/dl, a hematocrit of 37.2% and a 
C-reactive protein count of 0.64 mg/dl. The serum levels of 
neuron‑specific enolase were elevated to 156.7 ng/ml. X-ray 
and computed tomography (CT) scans of the chest revealed an 
ill‑defined mass in the upper lobe of the right lung, with ipsilat-
eral mediastinal lymph node swelling (Fig. 1). A bronchoscopy 
revealed a well-circumscribed movable tumor located at the 
right B3 bronchus. The tumor obstructed ~90% of the lumen 
and the scope was not able to pass through this region (Fig. 2). 
Using the bronchoscopy, the whole of the mobile section of 
the endobronchial tumor was removed easily. Following the 
removal of the endobronchial tumor, the distal bronchus 
demonstrated narrowing by a sub-mucosal tumor.
Pathological analysis. The pathological examination of the 
tumor was consistent with a diagnosis of SCLC (Fig. 3). An 
immunohistochemical examination revealed positive staining 
for CD-56 (Fig. 4A) and chromogranin (Fig. 4B). 
Clinical course. Brain magnetic resonance imaging, abdominal 
ultrasonography and bone scintigraphy scans did not identify 
a malignancy. The tumor was diagnosed as limited-disease 
SCLC. The patient received chemoradiotherapy containing 
four courses of cisplatin (80 mg/m2, day 1) and etoposide 
(100 mg/m2, days 1-3), which resulted in a partial response. At 
six months after the initial therapy, the patient exhibited local 
recurrence. Despite the second to fourth lines of chemotherapy 
being less effective, tumor growth at the primary site was not 
as rapid as previously observed and no distant metastasis was 
identified. However, 22 months after the initiation of the first 
course of chemotherapy, the patient succumbed to SCLC.
Discussion
Radiographical manifestations of endobronchial lesions are 
considerably variable. Lobar or segmental atelectasis and 
pneumonic infiltration are commonly observed. The radio-
logical differential diagnosis of an endobronchial mass lesion 
includes non-malignant tumors, endobronchial metastasis of 
carcinoma from extrapulmonary organs and primary lung 
carcinoma (3-8). In addition, the mass-like pulmonary opacity, 
commonly caused by endobronchial infections, including 
mucus plugs distal to a centrally obstructing lesion due to a 
fungus or tuberculosis, also simulate an endobronchial mass 
on CT scans (9-11). In the current patient, an ill‑defined mass in 
the upper lobe of the right lung was identified, with ipsilateral 
mediastinal lymph node swelling. Therefore, an endobronchial 
lesion was not diagnosed in this patient until the bronchoscopy 
examination.
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It is generally accepted that the bronchoscopic findings of 
endobronchial lesions of primary lung carcinoma are difficult 
to distinguish from those of metastatic lung carcinoma and 
non-malignant tumors (12,13). Bronchoscopic examinations 
are used for the diagnosis of endobronchial lesions as the 
majority of lesions are within the view and range of the bron-
choscopic field. In specific cases, the value of bronchoscopic 
examinations may be limited as the admixture of necrotic 
material may prevent the collection of a sufficient specimen 
for diagnosis (9-11), however, the formation of a pathological 
diagnosis using specimens obtained by a bronchoscopic 
biopsy is mandatory for the generation of a correct diag-
nosis. Non-malignant endobronchial tumors generally have a 
smooth surface with uniform color (14). The most common 
sites associated with endobronchial metastasis are the breast, 
kidney and colon (5-7). Metastatic endobronchial tumors often 
presents as polypoid or nodular lesions covered with necrotic 
material (15). Squamous cell carcinoma is the most common 
histological type of primary lung carcinoma in a central loca-
tion and with endobronchial extensions (4). In this cell type, 
polypoid lesions with a rough surface covered with necrotic 
material are the most predominant lesions (16,17). Although 
SCLC with endobronchial growth is extremely rare, specific 
cases have been reported (18,19). Ramaraju et al reported 
an unusual case of centrally-located combined SCLC with a 
squamous cell component, which was diagnosed by an endo-
bronchial lung biopsy (18). In addition, Lee et al presented the 
case of a 51-year-old male with SCLC and an endobronchial 
mass in the left main bronchus (19). In these cases, the tumors 
contained elements of SCLC mixed with a component of 
Figure 4. Immunohistochemical analysis revealing positive staining for 
(A) CD-56 and (B) chromogranin.
Figure 1. Chest computed tomography (CT) scan revealing an ill‑defined 
mass in the upper lobe of the right lung with ipsilateral mediastinal lymph 
node swelling.
Figure 2. Bronchoscopy revealing a well-circumscribed hypervascular mov-
able tumor located at the right B3 bronchus. The tumor obstructed ~90% of 
the lumen and the scope was not able to pass through the narrowed route. 
Figure 3. (A) Loupe view of a whole endobraonchial tumor and (B) micro-
scopic features of the endobronchial tumor from the right B3 bronchus.
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squamous cell carcinoma (18,19). Patients with combined 
SCLC have a higher incidence of peripheral lesions, and as a 
consequence, the central location of the tumor in the present 
case was unusual. The low incidence rate and often small 
and inadequate specimens obtained by bronchoscopic biopsy 
make it difficult to diagnose combined SCLC without surgical 
resection (20).
In the present case study, the SCLC originated endo-
bronchially from the upper lobe of the lung. Chest CT scans 
revealed that its location was central. A bronchoscopic 
examination identified an irregularly covered partly‑whitish 
tissue, representative of the necrotic material coverage. 
Bronchoscopically, squamous cell lung cancer was considered 
as a differential diagnosis, although no such component was 
observed pathologically in the present study. The tumor was 
not found to exhibit necrotic material or other cell types of 
lung cancer and an admixture of fibrin in the outer stratum 
was found, indicative of necrotic material.
Despite SCLC with endobronchial growth being an 
extremely rare tumor presentation, the clinical evaluation of 
this diagnosis in patients presenting with a pulmonary tumor 
adjacent to the bronchus and an endobronchial polypoid lesion 
must not overlooked.
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